Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

631 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group.
Morishima Y, Morishita Y, Tanimoto M, Ohno R, Saito H, Horibe K, Hamajima N, Naito K, Yamada K, Yokomaku S, et al. Morishima Y, et al. Among authors: ohno r. Blood. 1989 Nov 1;74(6):2252-6. Blood. 1989. PMID: 2804362 Free article.
No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group.
Ohno R, Hiraoka A, Tanimoto M, Asou N, Kuriyama K, Kobayashi T, Yoshida M, Teshima H, Saito H, Fujimoto K. Ohno R, et al. Blood. 1993 Jan 15;81(2):561-2. Blood. 1993. PMID: 7678520 Free article. Clinical Trial. No abstract available.
Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.
Ohno R, Yokomaku S, Okumara M, Tanimoto M, Morishita Y, Morishima Y, Kodera Y, Saito H. Ohno R, et al. Haematol Blood Transfus. 1990;33:304-8. doi: 10.1007/978-3-642-74643-7_55. Haematol Blood Transfus. 1990. PMID: 2182424 Clinical Trial. No abstract available.
Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia.
Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, Asou N, Kuriyama K, Jinnai I, Shimazaki C, Akiyama H, Saito K, Oh H, Motoji T, Omoto E, Saito H, Ohno R, Ueda R. Kiyoi H, et al. Among authors: ohno r. Blood. 1999 May 1;93(9):3074-80. Blood. 1999. PMID: 10216104 Free article. Clinical Trial.
Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage.
Ito Y, Tanimoto M, Kumazawa T, Okumura M, Morishima Y, Ohno R, Saito H. Ito Y, et al. Among authors: ohno r. Cancer. 1989 Apr 15;63(8):1534-8. doi: 10.1002/1097-0142(19890415)63:8<1534::aid-cncr2820630813>3.0.co;2-n. Cancer. 1989. PMID: 2564311
631 results